In Vitro Release Mechanisms of Doxorubicin From a Clinical Bead Drug-Delivery System.
The release rate of doxorubicin (DOX) from the drug-delivery system (DDS), DC Bead, was studied by 2 miniaturized in vitro methods: free-flowing and sample reservoir. The dependencies of the release mechanisms on in vitro system conditions were investigated experimentally and by theoretical modeling. An inverse relationship was found between release rates and bead size, most likely due to the greater total surface area. The release rates correlated positively with temperature, release medium volume, and buffer strength, although the release medium volume had larger effect than the buffer strength. The sample reservoir method generated slower release rates, which described the in vivo release profile more accurately than the free-flowing method. There was no difference between a pH of 6.3 or 7.4 on the release rate, implying that the slightly acidic tumor microenvironment is less importance for drug release. A positive correlation between stirring rate and release rate for all DDS sizes was observed, which suggests film controlled release. Theoretical modeling highlighted the influence of local equilibrium of protonation, self-aggregation, and bead material interactions of DOX. The theoretical release model might describe the observed larger sensitivity of the release rate to the volume of the release medium compared to buffer strength. A combination of miniaturized in vitro methods and theoretical modeling are useful to identify the important parameters and processes for DOX release from a micro gel-based DDS.
Department of Pharmacy, Uppsala University, Uppsala 751 23, Sweden.
Emelie
E
Ahnfelt
Department of Pharmacy, Uppsala University, Uppsala 751 23, Sweden.
Erik
E
Sjögren
Department of Pharmacy, Uppsala University, Uppsala 751 23, Sweden.
Per
P
Hansson
Department of Pharmacy, Uppsala University, Uppsala 751 23, Sweden. Electronic address: hans.lennernas@farmaci.uu.se.
Hans
H
Lennernäs
D000903:Antibiotics, Antineoplastic / Q000737:chemistry / Q000493:pharmacokinetics; D004317:Doxorubicin / Q000737:chemistry / Q000493:pharmacokinetics*; D016503:Drug Delivery Systems / Q000379:methods*; D065546:Drug Liberation; D008863:Microspheres; D008956:Models, Chemical
D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin
controlled release; diffusion; dissolution; dissolution rate; drug-delivery systems; in vitro models; mathematical model; microspheres